+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
Healthy Volunteers
ID06849037

Comparing Maternal and Neonatal Infectious Morbidity in Women With Meconium-Stained Amniotic Fluid Treated With Prophylactic Antibiotics Zinacef Versus Placebo at Term

Led by Western Galilee Hospital-Nahariya · Updated on 2026-09-15

182

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying women with meconium-stained amniotic fluid at term to compare maternal and newborn infection rates between those treated with prophylactic antibiotics zinacef and those given a placebo. This randomized controlled double-blind trial aims to better understand how meconium staining relates to infections such as chorioamnionitis and neonatal sepsis, and to assess the types of bacteria present in infected cases. Participants are assigned to one of two groups one receives zinacef antibiotic treatment at 750 mg three times daily, while the other receives a placebo consisting of intravenous saline in the same volume and frequency. This study evaluates the effects of these treatments during labor and shortly after birth. During the trial, women and their newborns will be monitored for infections occurring within seven days around delivery. Researchers will track fever during labor and up to two hours postpartum, antibiotic use in newborns, and neonatal intensive care admissions within one week. This monitoring helps assess the safety and infection outcomes related to the treatments. Participation lasts through labor and up to one week postpartum with close observation.

CONDITIONS

Brief Title

Comparing Infectious Morbidity Among Women With Meconium-stained Amniotic Fluid at Term, Between Those Treated With Prophylactic Antibiotics Zinacef vs. Placebo

Research Team

M

Maya Frank Wolf, prof.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here